- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Gw Pharmaceuticals Share News (GWP)
Share News for Gw Pharmaceuticals (GWP)
| Share Price: 50.00 | Bid: 42.00 | Ask: 70.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
UPDATE 1-Cannabis medicine firm GW Pharma raises $11.2 mln
LONDON, Aug 6 (Reuters) - GW Pharmaceuticals, which makes cannabis-based medicine for treating the symptoms of multiple sclerosis, said on Thurs[6 Aug '09]
BRIEF-GW Pharmaceuticals raises $11.2m
LONDON, Aug 6 (Reuters) - GW Pharmaceuticals Plc: * Prominent US healthcare fund subscribes for significant equity stake in GW * Has s[6 Aug '09]
STOCKS NEWS UK-GW higher after manufacturing approval
STOCKS NEWS Reuters Results diary Europe Real-time Equity News[16 Jul '09]
BRIEF-GW gets UK manufacturing licence for sativex
LONDON, July 16 (Reuters) - GW Pharmaceuticals Plc: * Receives UK commercial manufacturing licence for Sativex ((London Equities News[16 Jul '09]
BRIEF-GW collaborates with Avandia creator
LONDON, June 16 (Reuters) - GW Pharmaceuticals Plc: * Collaborates with Avandia creator Cawthorne to research cannabinoids to tackle[16 Jun '09]
UPDATE 3-GW Pharma files cannabis drug for MS in Europe
By Ben Deighton and Ben Hirschler LONDON, May 20 (Reuters) - A pioneering cannabis-based medicine for multiple sclerosis from GW Pharmaceut[20 May '09]
STOCKS NEWS UK SMALL-GW higher on cannabis drug hopes
STOCKS NEWS Reuters Results diary Europe Real-time Equity News UK[20 May '09]
UPDATE 2-Bayer's Nexavar gets Japan OK for liver cancer
By Michael Shields and Ben Hirschler FRANKFURT/LONDON, May 20 (Reuters) - Bayer AG's Nexavar drug won Japanese regulatory approval for trea[20 May '09]
